A Star in deal with AUM Biosciences and One Biomed

In two separate dealings, AUM Biosciences has licensed its first novel, highly selective anti-cancer drug from A*STAR's Experimental Therapeutics Centre (ETC) and A*STAR's Institute of Microelectronics (IME) and One BioMed have launched a S$9 million joint lab.

Dec 05, 2018

By : Team ABLE

Dr. Ashis Kumar Sen conferred Swarnajayanti Fellowship for his work on cancer and dengue detection

Dr. Ashis Kumar Sen is one among the three Professors to receive this Fellowship in Engineering Sciences discipline from the entire country. His main research interests are in the areas of microfluidics based interfacial phenomena and healthcare diagnostics.

Dec 04, 2018

By : Team ABLE

Meet Biotech regulators

All key biotech regulators and policy makers will be available to interact and handle various queries from biotech companies at 3 pm, this Friday, December 7, 2018.

Dec 03, 2018

By : Team Able